MAP6 and schizophrenia: Second, a small peptide motif called NAP—present in Activity-Dependent Neuroprotective Protein (ADNP), which is dysregulated in schizophrenia and in autism (Gozes, 2011; Hacohen-Kleiman et al., 2018; Van Dijck et al., 2019)—partially alleviates cognitive impairments in MAP6 heterozygous mice (Merenlender-Wagner et al., 2010; Volle et al., 2013).